Abstract

e12555Background: CD44 variant 9 (CD44v9), a splicing variant of CD44, has emerged as a novel marker of cancer stemness in a variety of solid tumors. CD44v9 has been shown to be correlated with the...

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call